Latest News-Wuxi Biologics Mediaroom_Page

WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates

WUXI, China and DAEJEON, South Korea, June 10, 2021 /PRNewswire/ -- WuXi XDC ("XDC"), a global CDMO...

2021-06-10 08:30 4788

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership

SHANGHAI and ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2021-05-27 08:30 5260

WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services

WUXI, China, May 14, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company w...

2021-05-14 08:30 4998

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with ...

2021-05-07 08:30 4974

WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC

SHANGHAI, April 13, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company wi...

2021-04-13 17:00 2408

WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA

WUXI, China, April 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company ...

2021-04-07 08:22 22591

2020 Results Record High Despite a Challenging Year

Revenue Increased by 40.9% Y-o-Y to RMB5,612 Million Gross Profit Rose by 52.7% Y-o-Y to RMB2,533 Mi...

2021-03-23 20:59 4037

WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group

SUZHOU, China, March 18, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global compa...

2021-03-18 08:59 3306

WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China

HANGZHOU, China, March 17, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global com...

2021-03-17 08:45 3275

WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19

SHANGHAI and DUNDALK, Ireland, March 16, 2021 /PRNewswire/ -- WuXi Vaccines, a world-leading vaccin...

2021-03-16 16:30 2881

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility

WUXI, China, March 3, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company ...

2021-03-03 18:23 2080

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories

SHANGHAI, Feb. 25, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company wit...

2021-02-25 08:00 2203

The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics

* Greatly increase the company's current capacity to 90,000L and enable WuXi Biologics to initiat...

2021-02-09 08:25 2290

WuXi Biologics Receives GMP Certification from Brazil's ANVISA

* First company in China to receive GMP certification for the production of biologics from the U....

2020-12-28 17:50 2344

WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer

* The DS facility (MFG19) with 3x1000L perfusion and 6x2000L fed-batch capacity for vaccines and ...

2020-12-21 21:02 2375

Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation

MUNICH and SHANGHAI, Dec. 2, 2020 /PRNewswire/ -- Tubulis, WuXi STA and WuXi Biologics today announ...

2020-12-02 19:00 2293

Latest News